Subscribe
shutterstock_1017640453_-ci-photos
CI Photos / Shutterstock.com
1 October 2019GeneticsRory O'Neill

CRISPR: A licence to heal

Few areas of emerging research have generated as much excitement in the life sciences community as CRISPR/Cas9, a gene-editing system which relies on the cas9 enzyme to alter DNA. But who invented it and who owns it?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
USPTO grants new CRISPR-Cas9 patent to University of California
3 October 2019   The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
USPTO grants new CRISPR-Cas9 patent to University of California
3 October 2019   The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.

More on this story

Americas
USPTO grants new CRISPR-Cas9 patent to University of California
3 October 2019   The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Kilpatrick adds ‘seasoned litigator’ as trademark partner
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler
Bayer, Orion take on Indian generic over $117bn drug
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Bankruptcy judge approves $305m sale of genetics testing company
Boies Schiller Flexner adds three-strong litigation team